Solid Biosciences (SLDB) Accumulated Depreciation & Amortization: 2017-2024
Historic Accumulated Depreciation & Amortization for Solid Biosciences (SLDB) over the last 6 years, with Mar 2024 value amounting to $13.1 million.
- Solid Biosciences' Accumulated Depreciation & Amortization rose 20.22% to $13.1 million in Q1 2024 from the same period last year, while for Mar 2024 it was $49.5 million, marking a year-over-year increase of 11.67%. This contributed to the annual value of $12.7 million for FY2023, which is 16.24% up from last year.
- According to the latest figures from Q1 2024, Solid Biosciences' Accumulated Depreciation & Amortization is $13.1 million, which was up 2.49% from $12.7 million recorded in Q4 2023.
- In the past 5 years, Solid Biosciences' Accumulated Depreciation & Amortization registered a high of $13.1 million during Q2 2022, and its lowest value of $5.8 million during Q1 2020.
- Its 3-year average for Accumulated Depreciation & Amortization is $11.8 million, with a median of $12.1 million in 2023.
- In the last 5 years, Solid Biosciences' Accumulated Depreciation & Amortization surged by 125.12% in 2020 and then declined by 13.61% in 2022.
- Over the past 5 years, Solid Biosciences' Accumulated Depreciation & Amortization (Quarterly) stood at $8.7 million in 2020, then soared by 33.83% to $11.7 million in 2021, then declined by 6.05% to $11.0 million in 2022, then increased by 16.24% to $12.7 million in 2023, then rose by 20.22% to $13.1 million in 2024.
- Its Accumulated Depreciation & Amortization was $13.1 million in Q1 2024, compared to $12.7 million in Q4 2023 and $12.1 million in Q3 2023.